← Eichor
Study identifier: NCT06956703 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

Condition: Gastro-Intestinal Disorder · Crohn Disease · Ulcerative Colitis  ·  Sponsor: University of Nottingham

PhaseN/A
Planned participants240
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this observational study is to learn about the comparisons of inflammatory markers between IBD and non-IBD (control) participants. The main question it aims to answer is: Are there differences in inflammatory markers between IBD and non-IBD (control) participants.

This description comes directly from the study's public registry record.

Talk to the study team

Gordon Moran Professor  ·  0115 9249924  ·  Gordon.Moran@nottingham.ac.uk

Nadia Frowd  ·  nadia.frowd1@nhs.net

Always discuss trial participation with your own doctor first.

Locations (1)

University of NottinghamNottingham, Nottinghamshire, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06956703